STOCKCHASE

What the experts are saying!
This site compiles comments that experts make about stocks while on public TV shows.

There are 6 registered members and 70 guests viewing the site.

Astrazeneca P L C
Symbol: AZN-N
Active: Y
Sector: biotechnology/pharmaceutical
Last Price: 41.650
Last Price Date: 2012-05-17 20:38:22
Globe 200 day average
Google Discussions (view only)
Yahoo Discussions (participate)


SELL ON STRENGTH	45.110	Srikanth Iyer	No, not a good entry point. Dividend for dividend sake it is a good stock. It is falling because Libitor is coming out of patent. It is an industry that is in a state of flux. It is falling off a patent cliff.	2012-03-16

DON'T BUY	40.410	David Baskin	You would think pharmaceuticals would be very recession resistant but it turns out it is a little more economically sensitive than would be thought. One of his concerns with the big research and development companies has been the growth of the generic companies. Also is concerned with litigation risk.	2008-11-06

Comment	36.620	Brendan Caldwell	Doesn't know this as well as some of the others. Stocks he likes the most in this sector are Abbott Labs (ABT-N) and Novartis (NVS-N), which have good pipelines and good growth potential.	2008-10-27

DON'T BUY	30.800	Clos Olsson	Facing growing competition.	2002-09-13